Loading…
Optimi Health Corp. is projected to decline to $4.77 by 2027, a -2% move from its current price of $4.85. OPTH is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $4.61 | $4.85 | $5.09 | -0.03% |
| Aug 6 | $4.52 | $4.85 | $5.20 | -0.05% |
| Aug 7 | $4.45 | $4.85 | $5.28 | -0.08% |
| Aug 8 | $4.39 | $4.84 | $5.35 | -0.11% |
| Aug 9 | $4.34 | $4.84 | $5.41 | -0.13% |
| Aug 10 | $4.29 | $4.84 | $5.47 | -0.16% |
| Aug 11 | $4.25 | $4.84 | $5.52 | -0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.25 | $4.84 | $5.52 | -0.18% |
| Week 2 | $4.02 | $4.83 | $5.82 | -0.37% |
| Week 3 | $3.84 | $4.82 | $6.05 | -0.55% |
| Week 4 | $3.70 | $4.81 | $6.26 | -0.74% |
| Week 5 | $3.59 | $4.81 | $6.44 | -0.92% |
| Week 6 | $3.48 | $4.80 | $6.61 | -1.10% |
| Week 7 | $3.39 | $4.79 | $6.77 | -1.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Optimi Health Corp. is a Canadian pharmaceutical and nutraceutical drug manufacturer. The company manufactures controlled substances including finished MDMA and psilocybin drug products and supplies them directly to authorized clinics, pharmacies, clinical trials, and partners.
It produces MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. It also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. Optimi Health Corp.
was incorporated in 2020 and is based in Princeton, Canada.
Optimi Health Corp. trades under the symbol OPTH and is currently priced at $4.92 with a market cap of $27.68M and a rank of 4583. The 30-day range is $3.40 to $7.12, with a support level at $4.01 and a resistance at $5.09.
Forecasts show near-term values around the current price, with a 2026 average of $4.92 (min $4.01, max $6.78) and a 2029 average of $5.26 (max $10.08). By 2030 the average rises to $7.19 (max $14.51) and continues toward 2050 with an average of $18.13 (max $41.69). The forecast also lists yearly ROIs of 0.0 in 2026, -3.1 in 2027, -4.3 in 2028, 6.9 in 2029, 46.1 in 2030, 43 in 2031, 21.2 in 2032, 26.7 in 2033, 9.5 in 2034, 31.6 in 2035, 42.8 in 2040, and 268.4 in 2050, with sentiment shifting to BULLISH from 2030 onward.
A major floor 26.4% below — a decisive break under it would weaken the trend.
The nearest floor, 17.3% below — buyers have tended to step in here.
The nearest ceiling, 4.9% above — a clean break opens room to run.
A major ceiling 25.4% above — clearing it would confirm fresh momentum.
Key OPTH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OPTH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.78 | Buy | $4.76 | Buy |
| MA 10 | $4.74 | Buy | $4.75 | Buy |
| MA 20 | $4.70 | Buy | $4.73 | Buy |
| MA 50 | $4.87 | Sell | $4.94 | Sell |
| MA 100 | — | Neutral | — | Neutral |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.32 | Neutral |
| Stoch RSI (14) | 89.50 | Sell |
| CCI (20) | 71.52 | Neutral |
| Williams %R (14) | -17.78 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 2.32 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 82.22 | Sell |
| TRIX (15) | -0.11 | Sell |
| Awesome (5,34) | 0.16 | Buy |
| Ultimate (7,14,28) | 61.40 | Neutral |
| Momentum (10) | -0.16 | Sell |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 4.75 | Buy |
| ADX (14) | 8.55 | Neutral |
| ATR (14) | 0.19 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 50. SMA50 and SMA200 data are not provided in the snapshot. The stock shows a support level at $4.01 and a resistance at $5.09, with a 30-day price range of $3.40 to $7.12.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.01 | $4.85 | $6.49 | 0% | Neutral | |
| $3.21 | $4.77 | $7.67 | -2% | Neutral | |
| $2.96 | $4.83 | $8.45 | 0% | Neutral | |
| $2.93 | $5.20 | $9.66 | +7% | Neutral | |
| $3.64 | $6.96 | $13.61 | +44% | Bullish | |
| $3.36 | $6.93 | $14.13 | +43% | Bullish | |
| $2.67 | $5.93 | $12.55 | +22% | Bullish | |
| $2.81 | $6.25 | $13.68 | +29% | Bullish | |
| $2.50 | $5.57 | $12.57 | +15% | Neutral | |
| $2.92 | $6.50 | $14.94 | +34% | Bullish | |
| $3.34 | $7.43 | $17.09 | +53% | Bullish | |
| $7.91 | $17.58 | $40.43 | +262% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.01 | $4.85 | $5.72 | +0.00% |
| September 2026 | $3.71 | $4.62 | $6.05 | -4.75% |
| October 2026 | $3.73 | $4.73 | $6.38 | +2.49% |
| November 2026 | $3.53 | $4.55 | $6.26 | -3.93% |
| December 2026 | $3.53 | $4.63 | $6.49 | +1.71% |
Click any year to see its month-by-month OPTH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, OPTH could reach as high as $6.49, with a base case around $4.85 and support toward $4.01 — roughly 0% from $4.85. Price action looks broadly range-bound.
Expect OPTH to range from $3.21 to $7.67 through 2027. The $4.77 average target implies a -2% move from current prices. That is -2% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The OPTH price prediction for 2028 points to an average of $4.83 (low $2.96, high $8.45) — a potential decline of 0% on today's $4.85. Price action looks broadly range-bound.
In 2029, OPTH is projected to trade between $2.93 and $9.66, averaging $5.20 — a potential gain of +7% from today's $4.85. That is up +8% on the projected 2028 average. A consolidation phase looks the most probable path here.
Optimi Health Corp.'s 2030 outlook centres on $6.96, within a $3.64 to $13.61 range. That is up +34% on the projected 2029 average. That marks a +44% change versus current levels. Momentum favours further upside here.
By 2031, OPTH could reach as high as $14.13, with a base case around $6.93 and support toward $3.36 — roughly +43% from $4.85. Buyers look set to stay in control over this stretch.
Expect OPTH to range from $2.67 to $12.55 through 2032. The $5.93 average target implies a +22% move from current prices. That is -14% versus the projected 2031 average. Momentum favours further upside here.
The OPTH price prediction for 2033 points to an average of $6.25 (low $2.81, high $13.68) — a potential gain of +29% on today's $4.85. Buyers look set to stay in control over this stretch.
In 2034, OPTH is projected to trade between $2.50 and $12.57, averaging $5.57 — a potential gain of +15% from today's $4.85. That is -11% versus the projected 2033 average. Price action looks broadly range-bound.
Optimi Health Corp.'s 2035 outlook centres on $6.50, within a $2.92 to $14.94 range. That is up +17% on the projected 2034 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, OPTH could reach as high as $17.09, with a base case around $7.43 and support toward $3.34 — roughly +53% from $4.85. Momentum favours further upside here.
Expect OPTH to range from $7.91 to $40.43 through 2050. The $17.58 average target implies a +262% move from current prices. That is up +137% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in OPTH today (≈ 206.185567 OPTH) could be worth
$3,624.09
+$2,624.09 (+262%) by 2050 · US Dollar
Based on the average projected OPTH price of $17.58 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OPTHwould be worth at today's price.
$1,000 invested in OPTH on May 20, 2026 (≈ 164.473686 OPTH) would be worth
$797.7
-$202.3 (-20.2%) today · 0.80× · US Dollar
Based on a OPTH entry price of $6.08 vs. today's $4.85.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.68 | $1,036.32 | +3.6% |
| 1 month ago | $5 | $970 | -3.0% |
| All time ago | $6.08 | $797.7 | -20.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OPTH forecast.
Our base-case forecast reaches $9.70 around 2050.
Implied market cap at $9.70: $54.57M
In the multi-year forecast, the price path turns bullish starting in 2030, with an average price of $7.19 and a 2030 ROI of 46.1. The 2040 forecast shows an average of $7.03 with a ROI of 42.8, and by 2050 the average is $18.13 with a max of $41.69 and a ROI of 268.4. Past the 2026 neutral period, the forecast remains bullish in 2030 and beyond, with 2031 at an average of $7.03 and 2032 at $5.96, then rising again in 2033 to $6.23 and 2034 to $5.39 before reaching $6.48 in 2035.
The path includes some years with lower or negative ROIs (e.g., 2027 -3.1 and 2028 -4.3) and a neutral year in 2034 (ROI 9.5), illustrating a varied risk/return landscape across the horizon. The longest-term view envisions substantial upside by 2050, reflecting a potential max of $41.69 and an average near $18.13, but these are estimates and carry uncertainty.
Tap a question to reveal the answer.
In 2030 the average forecast price is $7.19, with a max of $14.51 and a min of $3.55; ROI is 46.1; sentiment is BULLISH.
The forecast shows a path to higher prices in 2030-2050, with the 2030 average $7.19 and 2050 average $18.13, and a max of $41.69. However, some earlier years show negative ROI (-3.1 in 2027 and -4.3 in 2028) and neutral signals in parts of the horizon; these are estimates and not guarantees.
The forecast includes a 2029 max of $10.08 and a 2030 max of $14.51, indicating $10 is within the projected upper range in the near term.
For 2050, the average forecast is $18.13 with a max of $41.69 and a min of $8.16; ROI is 268.4 and sentiment is BULLISH.
The current price is $4.92.
Optimi Health Corp. Community Discussion
0Share your Optimi Health Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.